Clinical trials
Completed Acquired Immunodeficiency Syndrome trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
66 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2004 | 1 |
| 2005 | 4 |
| 2007 | 5 |
| 2008 | 4 |
| 2009 | 4 |
| 2010 | 3 |
| 2011 | 6 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 5 |
| 2016 | 3 |
| 2017 | 6 |
| 2018 | 1 |
| 2019 | 4 |
| 2020 | 3 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 66 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ViiV Healthcare | 22 |
| Gilead Sciences | 7 |
| Tibotec Pharmaceuticals, Ireland | 6 |
| Imperial College London | 4 |
| Chelsea and Westminster NHS Foundation Trust | 3 |
| Janssen-Cilag International NV | 3 |
| Janssen R&D Ireland | 2 |
| Kirby Institute | 2 |
| National Institute of Allergy and Infectious Diseases (NIAID) | 2 |
| Aarhus University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Acquired Immunodeficiency Syndrome | 66 |
| HIV Infections | 32 |
| Infections | 15 |
| Cytomegalovirus Infections | 3 |
| Tuberculosis | 2 |
| AIDS-Related Opportunistic Infections | 1 |
| Creutzfeldt-Jakob Syndrome | 1 |
| Cytomegalovirus Retinitis | 1 |
| Hepatitis | 1 |
| Hepatitis B | 1 |
Trials
Showing 1 to 25 of 66. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.